Prosecution Insights
Last updated: August 06, 2026

Premier Biotech LLC

4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (50%)
2
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (50%)
Double-patenting only2 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
25% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PATEL, NIDHI NIRAJ 1 54.2% +46.1%
KRCHA, MATTHEW D 1 65.2% +35.4%
GERHARD, ALISON CLAIRE 1 27.8% +32.4%
SIEFKE, SAMUEL P 1 63.1% +17.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17970001 DEVICE FOR TESTING AN ANALYTE IN A LIQUID SAMPLE GERHARD, ALISON CLAIRE

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
16875583 SCREENING DEVICE FOR ANALYSIS OF BODILY FLUIDS SIEFKE, SAMUEL P 100d overdue
18775773 DEVICE AND METHOD FOR SPLIT SALIVA COLLECTION AND TESTING PATEL, NIDHI NIRAJ
18703518 DEVICE FOR DETECTING ANALYTE IN FLUID SAMPLE KRCHA, MATTHEW D
17970001 DEVICE FOR TESTING AN ANALYTE IN A LIQUID SAMPLE GERHARD, ALISON CLAIRE

Top Art Units

Art UnitApps
3791 1
1797 1
1758 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18775773 DEVICE AND METHOD FOR SPLIT SALIVA COLLECTION AND TESTING PATEL, NIDHI NIRAJ 3791 §103 Non-Final OA Pending Jul 17, 2024
18703518 DEVICE FOR DETECTING ANALYTE IN FLUID SAMPLE KRCHA, MATTHEW D DP Non-Final OA Pending Apr 22, 2024
17970001 DEVICE FOR TESTING AN ANALYTE IN A LIQUID SAMPLE GERHARD, ALISON CLAIRE 1797 §103 Final Rejection Pending Oct 20, 2022
16875583 SCREENING DEVICE FOR ANALYSIS OF BODILY FLUIDS SIEFKE, SAMUEL P 1758 DP Final Rejection 100d overdue Pending May 15, 2020

Managing Premier Biotech LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month